Phospholipase Inhibitors

Histone H3 is one of the five main histone proteins involved in the structure of chromatin in eukaryotic cells. Featuring a main globular domain and a long N-terminal tail, H3 is involved with the structure of the nucleosomes of the &#8242beads on

Mitochondrial Rho GTPase (UniProt: A1L1L6 also known as Miro1) is encoded by the Rhot1 (also known as Rnf135, rCG34120) gene (Gene ID: 303351) in rat. Miro1 is a single-pass type IV membrane protein with a transmembrane domain (aa 605-627).

ULK1 or autophagy-related protein 1 homolog (ATG1) is a serine/threonine protein kinase. It is a ubiquitously expressed protein that is highly abundant in the brain, skeletal muscle, and heart.

Caveolin-1 (UniProt: Q03135) is encoded by the CAV1 (also known as CAV) gene (Gene ID: 857) in human. Three caveolin genes are expressed in mammals and are designated as caveolin-1, -2, and -3.

Low-density lipoprotein receptor-related protein 6 (UniProt: O75581 also known as LRP-6) is encoded by the LRP6 gene (Gene ID: 4040) in human. LRP-6 is a disulfide-linked homodimeric, single-pass type I transmembrane protein, which is a component

Low-density lipoprotein receptor-related protein 6 (UniProt: O75581 also known as LRP-6) is encoded by the LRP6 gene (Gene ID: 4040) in human. LRP-6 is a disulfide-linked homodimeric, single-pass type I transmembrane protein, which is a component

Anti-Phosphotyrosine antibody (05-321), cross-linked to protein A agarose by dimethylpimelimidate Some of the tyrosine residues can be tagged with a phosphate group (phosphorylated) by protein kinases. (In its phosphorylated state, it is referred

Protein tyrosine phosphorylation was first described in 1979. Large numbers of tyrosine kinases have been described since, and many of the signaling pathways initiated by tyrosine phosphorylation have been delineated.

Some of the tyrosine residues can be tagged with a phosphate group (phosphorylated) by protein kinases. (In its phosphorylated state, it is referred to as phosphotyrosine.

Anti-PIRT phosphoinositide-interacting regulator of transien

Anti-PIRT phosphoinositide-interacting regulator of transien

A set of eight ready to use cell-permeable, irreversible inhibitors of various caspase-family proteases. Contains 25 &#181l (2 mM) each of Caspase-1 Inhibitor VI, Z-YVAD-FMK (Cat.